Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Kern

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|October 11, 2018
Mehran in-stent restenosis classification adapted for coronary bifurcations: the impact on 4-year follow-up from randomized clinical studies POLBOS I and IIJacek Bil, Robert J Gil, Adam Kern, et al.
Frontiers in Cardiovascular Medicine|July 18, 2022
Complete Blood Count-Derived Indices as Prognostic Factors of 5-Year Outcomes in Patients With Confirmed Coronary Microvascular SpasmJacek Bil, Natalia Pietraszek, Robert J Gil, et al.
Cardiology Journal|July 18, 2017
Dedicated bifurcation stents or regular drug eluting stents in distal left main stenosis: A retrospective studyAdam Kern, Robert J Gil, Krystian Bojko, et al.
Cardiology Journal|May 26, 2017
The approach to coronary bifurcation treatment and its outcomes in Poland: The single center experienceAdam Kern, Robert J Gil, Krystian Bojko, et al.
Kardiologia Polska|September 15, 2022
When an interventional cardiologist needs to be a vascular surgeon: Successful management of coronary stent loss in a nonagenarianAdam Kern, Tomasz Godlewski, Robert Gil, et al.
European Journal of Clinical Investigation|May 31, 2017
Platelet distribution width as the prognostic marker in coronary bifurcation treatmentAdam Kern, Robert J Gil, Krystian Bojko, et al.
Medicine|April 5, 2019
Rationale and design of the randomized, multicenter, open-label, controlled POLBOS 3 trial aimed to compare regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM C stentRobert J Gil, Tomasz Pawłowski, Jacek Legutko, et al.
Journal of Pediatric Urology|September 17, 2013
Role of urethral bulking agents in epispadias-exstrophy complex patientsBhavik B Shah, Eric Z Massanyi, Heather Dicarlo, et al.
European Journal of Clinical Investigation|March 30, 2021
6-year results of BiOSS stents in coronary bifurcation treatmentRobert J Gil, Adam Kern, Radoslaw Formuszewicz, et al.
Journal of Personalized Medicine|December 23, 2023
Significance of S100B Protein as a Rapid Diagnostic Tool in Emergency Departments for Traumatic Brain Injury PatientsRakesh Jalali, Izabela Godlewska, Magdalena Fadrowska-Szleper, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|October 11, 2018
Mehran in-stent restenosis classification adapted for coronary bifurcations: the impact on 4-year follow-up from randomized clinical studies POLBOS I and IIJacek Bil, Robert J Gil, Adam Kern, et al.
Frontiers in Cardiovascular Medicine|July 18, 2022
Complete Blood Count-Derived Indices as Prognostic Factors of 5-Year Outcomes in Patients With Confirmed Coronary Microvascular SpasmJacek Bil, Natalia Pietraszek, Robert J Gil, et al.
Cardiology Journal|July 18, 2017
Dedicated bifurcation stents or regular drug eluting stents in distal left main stenosis: A retrospective studyAdam Kern, Robert J Gil, Krystian Bojko, et al.
Cardiology Journal|May 26, 2017
The approach to coronary bifurcation treatment and its outcomes in Poland: The single center experienceAdam Kern, Robert J Gil, Krystian Bojko, et al.
Kardiologia Polska|September 15, 2022
When an interventional cardiologist needs to be a vascular surgeon: Successful management of coronary stent loss in a nonagenarianAdam Kern, Tomasz Godlewski, Robert Gil, et al.
European Journal of Clinical Investigation|May 31, 2017
Platelet distribution width as the prognostic marker in coronary bifurcation treatmentAdam Kern, Robert J Gil, Krystian Bojko, et al.
Medicine|April 5, 2019
Rationale and design of the randomized, multicenter, open-label, controlled POLBOS 3 trial aimed to compare regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM C stentRobert J Gil, Tomasz Pawłowski, Jacek Legutko, et al.
Journal of Pediatric Urology|September 17, 2013
Role of urethral bulking agents in epispadias-exstrophy complex patientsBhavik B Shah, Eric Z Massanyi, Heather Dicarlo, et al.
European Journal of Clinical Investigation|March 30, 2021
6-year results of BiOSS stents in coronary bifurcation treatmentRobert J Gil, Adam Kern, Radoslaw Formuszewicz, et al.
Journal of Personalized Medicine|December 23, 2023
Significance of S100B Protein as a Rapid Diagnostic Tool in Emergency Departments for Traumatic Brain Injury PatientsRakesh Jalali, Izabela Godlewska, Magdalena Fadrowska-Szleper, et al.
Pageof 7